Brainsway Ltd. — Regulatory Filings 2021

Feb 22, 2021

6-K 1 form6-k.htm

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2021

Commission File Number: 001-35165

BRAINSWAY LTD.

(Translation of registrant’s name into English)

19 Hartum Street

Bynet Building, 3rd Floor

Har HaHotzvim

Jerusalem, 9777518, Israel

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F [ X ] Form 40-F [ ]

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

EXHIBIT INDEX

Exhibit	Title
99.1	BrainsWay LTD. Unaudited Condensed Interim Consolidated Financial Statements as of September 30, 2020

101.INS	XBRL Instance File
101.SCH	XBRL Schema File
101.CAL	XBRL Calculation File
101.DEF	XBRL Definition File
101.LAB	XBRL Labels File
101.PRE	XBRL Presentation File

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| | BRAINSWAY
LTD. |
| --- | --- |
| | (Registrant) |
| Date:
February 22, 2021 | /s/
Christopher R. von Jako, Ph.D |
| | Christopher
R. von Jako, Ph.D |
| | President
and Chief Executive Officer |

Field: Page; Sequence: 3; Options: Last

Field: /Page